Exploring lipin1 as a promising therapeutic target for the treatment of Duchenne muscular dystrophy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Exploring lipin1 as a promising therapeutic target for the treatment of Duchenne muscular dystrophy ; volume:22 ; number:1 ; day:16 ; month:7 ; year:2024 ; pages:1-18 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (16.7.2024), 1-18, 12.2024
- Urheber
-
Jama, Abdulrahman
Alshudukhi, Abdullah A.
Burke, Steve
Dong, Lixin
Kamau, John Karanja
Morris, Brooklyn
Alkhomsi, Ibrahim A.
Finck, Brian N.
Voss, Andrew Alvin
Ren, Hongmei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05494-z
- URN
-
urn:nbn:de:101:1-2410091007287.596927208054
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jama, Abdulrahman
- Alshudukhi, Abdullah A.
- Burke, Steve
- Dong, Lixin
- Kamau, John Karanja
- Morris, Brooklyn
- Alkhomsi, Ibrahim A.
- Finck, Brian N.
- Voss, Andrew Alvin
- Ren, Hongmei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Survival in Duchenne muscular dystrophy
Therapeutic opportunities and clinical outcome measures in Duchenne muscular dystrophy
Pain characterization in Duchenne muscular dystrophy
Targeting angiogenesis in Duchenne muscular dystrophy
Cognition trajectory in Duchenne muscular dystrophy
Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy
Duchenne muscular dystrophy: classical and new therapeutic purposes and future perspectives
Vascular-targeted therapies for Duchenne muscular dystrophy
Left ventricular noncompaction in Duchenne muscular dystrophy
The Duchenne muscular dystrophy gene and cancer
Strategies for molecular therapy of Duchenne muscular dystrophy
Improving clinical trial design for Duchenne muscular dystrophy
Survival in Duchenne muscular dystrophy
Therapeutic opportunities and clinical outcome measures in Duchenne muscular dystrophy
Pain characterization in Duchenne muscular dystrophy
Targeting angiogenesis in Duchenne muscular dystrophy
Cognition trajectory in Duchenne muscular dystrophy
Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy
Duchenne muscular dystrophy: classical and new therapeutic purposes and future perspectives
Vascular-targeted therapies for Duchenne muscular dystrophy
Left ventricular noncompaction in Duchenne muscular dystrophy
The Duchenne muscular dystrophy gene and cancer
Strategies for molecular therapy of Duchenne muscular dystrophy
Improving clinical trial design for Duchenne muscular dystrophy
Survival in Duchenne muscular dystrophy
Therapeutic opportunities and clinical outcome measures in Duchenne muscular dystrophy
Pain characterization in Duchenne muscular dystrophy
Targeting angiogenesis in Duchenne muscular dystrophy
Cognition trajectory in Duchenne muscular dystrophy
Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy
Duchenne muscular dystrophy: classical and new therapeutic purposes and future perspectives
Vascular-targeted therapies for Duchenne muscular dystrophy
Left ventricular noncompaction in Duchenne muscular dystrophy
The Duchenne muscular dystrophy gene and cancer
Strategies for molecular therapy of Duchenne muscular dystrophy